Cargando…
Detection of amyloid in Alzheimer’s disease with positron emission tomography using [(11)C]AZD2184
PURPOSE: Current positron emission tomography (PET) radioligands for detection of Aβ amyloid in Alzheimer’s disease (AD) are not ideal for quantification. To improve the signal to noise ratio we have developed the radioligand [(11)C]AZD2184 and report here the first clinical evaluation. METHODS: Eig...
Autores principales: | Nyberg, Svante, Jönhagen, Maria Eriksdotter, Cselényi, Zsolt, Halldin, Christer, Julin, Per, Olsson, Hans, Freund-Levi, Yvonne, Andersson, Jan, Varnäs, Katarina, Svensson, Samuel, Farde, Lars |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Springer-Verlag
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2764092/ https://www.ncbi.nlm.nih.gov/pubmed/19495746 http://dx.doi.org/10.1007/s00259-009-1182-1 |
Ejemplares similares
-
Low background and high contrast PET imaging of amyloid-β with [(11)C]AZD2995 and [(11)C]AZD2184 in Alzheimer’s disease patients
por: Forsberg, Anton, et al.
Publicado: (2013) -
Kinetic analysis and test-retest variability of the radioligand [(11)C](R)-PK11195 binding to TSPO in the human brain - a PET study in control subjects
por: Jučaite, Aurelija, et al.
Publicado: (2012) -
PET imaging of [(11)C]PBR28 in Parkinson’s disease patients does not indicate increased binding to TSPO despite reduced dopamine transporter binding
por: Varnäs, Katarina, et al.
Publicado: (2018) -
GABA(A) receptor occupancy by subtype selective GABA(Aα2,3) modulators: PET studies in humans
por: Jucaite, Aurelija, et al.
Publicado: (2016) -
Synthesis, Biodistribution, and Radiation Dosimetry
of a Novel mGluR5 Radioligand: (18)F-AZD9272
por: Nag, Sangram, et al.
Publicado: (2020)